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Reframing non-communicable diseases as socially 
transmitted conditions 
In a Comment (February, 2017),1 we argued that 
action on the conditions currently referred to as non-
communicable diseases (NCDs) may be hampered by 
the inadequacy of their label. We received a remarkable 
amount of feedback on this suggestion, and in this 
Comment we synthesise the responses garnered from 
a Lancet Facebook poll, Correspondence letters,2–5 and 
a related GHD Online discussion. We also propose a new 
definition based on shared social drivers. 
The majority of respondents (29 of 47) to the 
Facebook poll thought that the NCD name should indeed 
be changed, and almost everyone acknowledged the 
limitations of the current label. Many NCDs are in fact 
communicable, and the current anti-definition provides 
no information about what unites these conditions. 
This makes it hard for politicians and the general public 
to grasp the main challenges posed by NCDs: a problem 
that is exacerbated by the implication that individual 
(rather than societal) factors are the key determinants.
The current misnomer is misleading but not 
completely useless: it has currency within the global 
health community and multiple donors, government 
departments, non-governmental organisations, 
and academic units use NCD in their own names and 
programme titles. Then there is the fact that the name 
itself does not matter at all, as long as the conditions 
and their drivers are being addressed.
Unfortunately our efforts to prevent and control 
NCDs have been underfunded, misdirected, and 
underwhelming to date.6 Most governments focus 
on individual lifestyle choices, and only a minority of 
developing countries have implemented WHO “best 
buys” such as tobacco taxation, salt reduction, and 
elimination of trans fats.7 There is a lot to gain by 







Biosocial and developmental diseases These terms highlight the central role of the anthropogenic trends and structures that are driving the 
pandemic. The preventable nature of NCDs and socioeconomic inequalities are also implied. These definitions 
exclude a number of existing NCDs where association with social factors is weak—eg, glaucoma, infertility, 
Parkinson’s disease.




Terms that emphasise chronicity
Chronic & lifestyle-related conditions These suggestions hinge on the fact that NCDs are life-long conditions. Chronicity characterises most of the 
existing NCDs, but also applies to many infectious diseases like HIV and tuberculosis. With these names the 
focus is on the disease course at the individual level rather than shared antecedents. The terms are non-










The major diseases Defined on the basis of global burden—may change over time
Cardiometabolic diseases Captures the leading cause of mortality but nothing else
Insidious killer diseases Conveys a sense of urgency but stigmatising to live with
Proximal disorders Focuses on shared risk factors but is quite an opaque term
Interactional diseases Biosocial framing that stresses political-economic factors
Complex chronic diseases (vs infectious 
chronic diseases)
Infers that complex solutions are required. Adoption would require changing the international classification of 
diseases
ABC (avoidable, behavioural, and 
chronic) diseases
Catchy term that includes three core characteristics but also applies to infectious diseases—eg, syphilis 
Blue and green Probably refers to the IHME visualisation of the global burden of disease, not very clear for the uninitiated
NCDs=non-communicable diseases. IHME=Institute for Health Metrics and Evaluation.
Table: Suggested alternatives to the term “non-communicable disease”, and comments thereon
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framing NCDs in the context of our contemporary 
understanding of these conditions. Similarly, there 
is little to lose by abandoning a term that does not 
resonate with the evidence or the general public.
The majority of suggestions for alternative names 
(table) either emphasised the chronicity of NCDs 
or the fact that they are driven by a common set of 
anthropogenic drivers. The striking heterogeneity 
speaks to the fact that NCDs mean many different things 
to different groups. It is also clear that the nondescript 
nature of the current label permits broad interpretation 
and recruitment of disparate parties, all flying the same 
banner but with many different agendas. 
There is no single thread that unites all NCDs 
and neatly separates them from classical infectious 
diseases. The current list of NCDs describes a 
ragtag group of leftovers that do not satisfy Koch’s 
postulates8 nor fit neatly into other categories. NCDs 
include congenital conditions (eg, Down’s syndrome 
and neural tube defects), degenerative conditions 
(prostatic hypertrophy, cataracts, and hearing loss), 
musculoskeletal problems (back pain, arthritis, gout), 
genitourinary conditions (infertility and kidney stones), 
mental health problems (depression, schizophrenia), 
and the “big four”—cardiovascular disease, cancer, 
chronic respiratory disease, and type 2 diabetes. 
Although there is no one core characteristic that 
unites all of the NCDs, a number of themes run through 
the current group:
•	 Chronicity:	many	NCDs	develop	over	time	in	response	
to chronic risk factor exposure
•	 Global	 burden:	many	of	these	 conditions	 constitute	
the leading causes of death and disability
•	 The	preventable	nature	of	many	NCDs
•	 Common	 proximal	 physiological	 risk	 factors:	
cholesterol, blood glucose, hypertension, obesity
•	 Common	 behavioural	 risk	 factors:	 tobacco,	 alcohol,	
physical inactivity, diet, indoor air pollution
•	 Common	 distal	 risk	 factors:	 economic,	 social,	 and	
environmental factors; urbanisation, globalisation, 
industrialisation, and poverty; all of which are 
complex issues requiring multisectoral action
•	 Common	 issues	 of	 injustice	 and	 socioeconomic	
inequalities in the international and intranational 
distribution of risk factors, morbidity, and mortality
We feel that the greatest need is for a reorientation 
towards addressing the commercial and social 
deter minants of NCDs, and the socioeconomic 
inequalities within and between countries. We would 
also like to see more funding for NCDs, commensurate 
with the global health and economic levies they impose, 
as well as concerted action toward the structural social 
and commercial determinants of health.
Other disease groupings have been defined on the 
basis of shared pathogenesis (eg, cancers), the systems 
they affect (eg, respiratory diseases), when they occur 
in the life course (neonatal and maternal conditions), 
and common behavioural antecedents (eg, sexually 
transmitted infections). We feel it is most appropriate 
to bind NCDs together using their common upstream 
drivers. We therefore propose the new term “socially 
transmitted conditions” (STCs). This label stresses 
the anthropogenic and socially contagious nature 
of the diseases: STCs are driven by urbanisation, 
industrialisation, and poverty, the availability of 
tobacco, alcohol, and processed foods, and physical 
inactivity. STCs also share a common set of solutions 
focused on addressing the complex and often unjust 
structure of society.
It is important not to absolve individuals of all 
responsibility for their own health and lifestyle choices, 
while highlighting the fact that our changing social 
environment strongly influences the set of choices 
available. The term “socially transmitted” shifts the 
implied locus of action upstream. The term also provides 
clarity by describing the core uniting characteristic of the 
disease group. 
Virtually all diseases are influenced by social factors to 
some degree, and we stress that STCs are distinguished 
by the common constellation of social drivers that they 
share. We also note that congenital and degenerative 
conditions are imperfectly captured by our new name. 
This is a pertinent issue for future discussion, since 
the current NCD response also tends to overlook these 
diseases (viz the 2011 UN High Level Meeting semantics9 
and the WHO best buy interventions7).
Despite these limitations, the preface “socially 
transmitted” is vastly more transparent, accurate, and 
tractable than “non-communicable”. Importantly, it also 
challenges the persisting misconception that individual 
greed and sloth are driving the global epidemiological 
transition. 
The recent move from “international health” to 
“global health” demonstrates that a name change can 
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helpfully galvanise the reconceptualization of an entire 
field. The responses to our initial article demonstrated 
that no-one has a very good grasp of what NCDs 
actually are in the first place. By proposing a coherent 
and internationally significant narrative we hope to 
stimulate greater action on the major drivers of the 
world’s most important conditions. 
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